Pharmacological characterization of presynaptic calcitonin gene-related peptide (CGRP) receptors on CGRP-containing vasodilator nerves in rat mesenteric resistance vessels
- PMID: 7507998
Pharmacological characterization of presynaptic calcitonin gene-related peptide (CGRP) receptors on CGRP-containing vasodilator nerves in rat mesenteric resistance vessels
Abstract
Rat mesenteric arteries are innervated by calcitonin gene-related peptide (CGRP)-containing vasodilator nerves (CGRP nerves). This study investigated the presence of presynaptic CGRP receptors on CGRP nerves and the receptors' role in the regulation of CGRP release from these nerves. The rat mesenteric vascular bed was perfused with Krebs' solution containing 7 microM methoxamine plus 5 microM guanethidine to produce active tone and block adrenergic neurotransmission. In this preparation, periarterial nerve stimulation (PNS;2 Hz) and bolus infusion of CGRP (50 pmol) caused a decrease in perfusion pressure caused by vasodilation. Vasodilator response to PNS was abolished by 0.3 microM tetrodotoxin and by 1 microM human CGRP[8-37] (CGRP[8-37]), a CGRP receptor antagonist, which also abolished the response to bolus infusion of CGRP. Perfusion of CGRP (0.03-0.5 nM) dose-dependently inhibited vasodilator response to PNS, whereas it did not affect the response to bolus infusion of CGRP. The inhibitory effect of CGRP (0.3 nM) was antagonized by CGRP[8-37] (3 and 10 nM). Lower concentrations of CGRP[8-37] (1-10 nM) potentiated the vasodilator response to PNS, but higher concentrations (100 nM-1 microM) inhibited the response. The vasodilator response to bolus infusion of CGRP was dose-dependently inhibited by CGRP[8-37]. Eel calcitonin (5 and 50 microM), forskolin (0.01 and 0.1 microM), 3-isobutyl-1-methylxanthine (0.3 and 1 microM) and cyclic 8-bromo-adenosine 3':5'-monophosphate (10 and 100 microM) had no effect on the PNS-induced vasodilation. These results suggest that CGRP nerves are endowed with presynaptic CGRP receptors, which regulate CGRP release from the nerves via a negative feedback mechanism.
Similar articles
-
Angiotensin inhibits neurotransmission of calcitonin gene-related peptide-containing vasodilator nerves in mesenteric artery of spontaneously hypertensive rats.J Pharmacol Exp Ther. 1998 Feb;284(2):508-15. J Pharmacol Exp Ther. 1998. PMID: 9454791
-
Role of calcitonin gene-related peptide-containing nerves in the vascular adrenergic neurotransmission.J Pharmacol Exp Ther. 1990 Jan;252(1):403-9. J Pharmacol Exp Ther. 1990. PMID: 1688944
-
Involvement of calcitonin gene-related peptide (CGRP) receptors in insulin-induced vasodilatation in mesenteric resistance blood vessels of rats.Br J Pharmacol. 1998 Apr;123(8):1684-90. doi: 10.1038/sj.bjp.0701779. Br J Pharmacol. 1998. PMID: 9605576 Free PMC article.
-
Paracrine control of mesenteric perivascular axo-axonal interaction.Acta Physiol (Oxf). 2011 Sep;203(1):3-11. doi: 10.1111/j.1748-1716.2010.02197.x. Epub 2010 Nov 9. Acta Physiol (Oxf). 2011. PMID: 20887357 Review.
-
[Calcitonin gene-related peptide and neural control of vascular tone].Nihon Yakurigaku Zasshi. 1993 Jan;101(1):1-15. doi: 10.1254/fpj.101.1_1. Nihon Yakurigaku Zasshi. 1993. PMID: 8444377 Review. Japanese.
Cited by
-
Perivascular Adipose Tissue: the Sixth Man of the Cardiovascular System.Cardiovasc Drugs Ther. 2018 Oct;32(5):481-502. doi: 10.1007/s10557-018-6820-z. Cardiovasc Drugs Ther. 2018. PMID: 30171461 Free PMC article. Review.
-
Bioactive beta-bend structures for the antagonist halpha CGRP(8 - 37) at the CGRP(1) receptor of the rat pulmonary artery.Br J Pharmacol. 2000 Mar;129(5):1049-55. doi: 10.1038/sj.bjp.0703152. Br J Pharmacol. 2000. PMID: 10696108 Free PMC article.
-
Pioglitazone opposes neurogenic vascular dysfunction associated with chronic hyperinsulinaemia.Br J Pharmacol. 2008 Apr;153(7):1388-98. doi: 10.1038/bjp.2008.8. Epub 2008 Feb 4. Br J Pharmacol. 2008. PMID: 18246090 Free PMC article.
-
Peptidergic modulation of synaptic transmission in the parabrachial nucleus in vitro: importance of degradative enzymes in regulating synaptic efficacy.J Neurosci. 1996 Oct 1;16(19):6046-55. doi: 10.1523/JNEUROSCI.16-19-06046.1996. J Neurosci. 1996. PMID: 8815887 Free PMC article.
-
Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats.Br J Pharmacol. 2017 Jul;174(13):2001-2014. doi: 10.1111/bph.13799. Epub 2017 May 2. Br J Pharmacol. 2017. PMID: 28369749 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials